Larry Goldstein, PhD. Larry Goldstein PhD, has many titles, one of which sums up his career perfectly, “Distinguished Professor”. Dr. Goldstein has distinguished himself on many fronts, making him an ideal addition to the governing Board of the California Institute for Regenerative Medicine (CIRM). Dr. Goldstein – everyone calls him Larry - is a Cell … Continue reading U.C. San Diego Scientist Larry Goldstein Joins Stem Cell Agency’s Board
Jonathan Thomas
UCSF Nursing Professor Joins CIRM Board
Elena Flowers, PhD, RN, newest member of the CIRM Board: Photo courtesy UCSF Elena Flowers, PhD, RN, an associate professor of physiological nursing at the University of California, San Francisco (UCSF) is joining the Board of the California Institute for Regenerative Medicine (CIRM), the state’s Stem Cell Agency. Dr. Flowers was appointed to the Board … Continue reading UCSF Nursing Professor Joins CIRM Board
A Month of CIRM: Where we’ve been, where we’re going
All this month we are using our blog and social media to highlight a new chapter in CIRM’s life, thanks to the voters approving Proposition 14. We are looking back at what we have done since we were created in 2004, and also looking forward to the future. We kick off this event with a … Continue reading A Month of CIRM: Where we’ve been, where we’re going
Holiday Message
Thank you
Bob Klein These last few days have been interesting on so many levels. First the presidential race has kept the nation on tenterhooks. Closer to home the vote count for Proposition 14, to refunded CIRM, has been painstakingly slow (by the way, painstakingly means “with great care and thoroughness” for which we thank all the … Continue reading Thank you
CIRM Board Approves Third Clinical Trial for COVID-19
Dr. Xiaokui Zhang (left), Dr. Albert Wong (center), and Dr. Preet Chaudhary (right) Today the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at Celularity to conduct a clinical trial for the treatment of COVID-19. This brings the total number of CIRM clinical trials to 64, including … Continue reading CIRM Board Approves Third Clinical Trial for COVID-19
CIRM Board invests $5 million in emergency funding for coronavirus
Coronavirus In response to the crisis caused by the COVID-19 virus in California and around the world the governing Board of the California Institute for Regenerative Medicine (CIRM) today held an emergency meeting to approve $5 million in rapid research funds targeting the virus. “These are clearly extraordinary times and they require an extraordinary response … Continue reading CIRM Board invests $5 million in emergency funding for coronavirus
Stem Cell Agency Board Approves 50th Clinical Trial
May 4th, 2011 marked a landmark moment for the California Institute for Regenerative Medicine (CIRM). On that day the Stem Cell Agency’s Board voted to invest in its first ever clinical trial, which was also the first clinical trial to use cells derived from embryonic stem cells. Today the Stem Cell Agency reached another landmark, … Continue reading Stem Cell Agency Board Approves 50th Clinical Trial
Peddling hope for thousands of dollars – a TV expose on one clinic offering unproven stem cell therapies
You may have seen an ad in your local paper, promoting a seminar on the “wonders” of stem cell therapies. They are becoming increasingly common all around the US. The ads talk about the ability of stem cells to heal everything from arthritis to autism. But what they don’t talk about is that they are … Continue reading Peddling hope for thousands of dollars – a TV expose on one clinic offering unproven stem cell therapies
California’s Stem Cell Agency Accelerates Treatments to Patients
The following article is an Op Ed that appeared in today's print version of the San Francisco Chronicle Biotechnology was born in California in the 1970s based on the discovery out of one of its universities and California is responsible for an industry that has impacted the lives of billions of people worldwide. In 2004, … Continue reading California’s Stem Cell Agency Accelerates Treatments to Patients
The Stem Cellar 